All results / Stories / Amy Stulick
Medical device giant Medtonic has launched InPen, the first FDA-cleared smart insulin pen for diabetes patients needing multiple daily injections.
Hospitals in the Valley region have started administering the COVID-19 vaccine made by Pfizer Inc.
COVID and asthma clinical trials get green lights.
Amgen Inc.’s partnerships have delivered a flurry of positive news
Valley Home Medical Supply Inc. in Canoga Park paid a $565,873 settlement after allegations arose that the company defrauded the federal government's Medicare and Tricare programs.
MannKind Corp. missed third-quarter earnings estimates by 1 cent, but enjoyed a net revenue increase for its flagship drug, inhalable insulin Afrezza.
The AIDS Healthcare Foundation in Los Angeles staged a socially distant protest at Amgen headquarters in Thousand Oaks in response to the biotech giant’s refusal to sell orphan drugs to nonprofit entities at a reduced price.
Human resources management provider Arcoro has partnered with Sage Construction and Real Estate.
Malibu Microbiome Meeting followed with live Q&A.
Progenabiome in Ventura shared its Malibu Microbiome Meeting earlier this month,
Quarterly report validates Simulations Plus’ acquisition of Lixoft earlier in the year.
Simulations Plus bought French medical software company Lixoft in April, despite a pandemic that hampered in-person communication.
The number of available intensive care unit beds has plummeted in Los Angeles County, with only 92 ICU beds available countywide.
MannKind Corp. announced it has acquired Pennsylvania-based QrumPharma Inc. for $3.5 million in cash and more than 3 million shares of its common stock.
Amgen Inc. has terminated its collaboration with Bay area startup Cytokinetics.
Agoura Hills biotech company A2 Biotherapeutics on Wednesday announced it has entered into a collaboration agreement with pharma giant Merck to further develop its cancer therapies.
Westlake Village BioPartners has announced two new funds totaling $500 million to invest in life science startups and construct lab facilities for them.
Amgen could manufacture treatment for COVID-19.
If Indianapolis-based pharma giant Eli Lilly & Co. is granted an emergency use authorization for its leading COVID-19 antibody candidate, Amgen Inc. will have to fulfill its side of a collaboration agreement very soon.
BIOTECH: VC firm to invest in startups that become tenants.
Two real estate deals have put the Conejo Valley’s biotech hub on the fast-track to expansion.
Valencia supplement maker meets demand for immune-enhancing and weight-loss treatments.
Valencia’s Leif Labs upgrades to a 112,000-square-foot facility.
Gluten-free food producer Caulipower has not felt the sting that others in the food industry have suffered during the pandemic, using its nimbleness to ensure supermarket shelves are stocked with its cauliflower-centric products.
LIST: Employment firms and clients find tech makes hiring flexible.
Employment firms see mixed reactions from clients in terms of hiring in the midst of a pandemic, with the impact varying based on the industry.
One of Jason Sands’ clients asked how he could help others financially during tough times.
Wealth manager Jason Sands sought to keep clients on track for their long-term goals during the year of crisis, while also meeting short-term needs.